Inflammatory response to colloids compared to crystalloid priming in cardiac surgery patients with cardiopulmonary bypass

Chinese Journal of Physiology

Volumn 55, Issue 3, 2012, Pages 210-218

  Liou, Huey Ling ^a   Shih, Chun Che ^b   Chao, Yann Fen C ^c   Lin, Nien Tsung ^d   Lai, Shau Ting ^a   Wang, Shu Hua ^a   Chen, Hsing I ^d  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c MACKAY MEDICAL COLLEGE   (Taiwan)

^d TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Cardiac surgery; Cardiopulmonary bypass; Inflammatory response; Priming solutions

Indexed keywords

C REACTIVE PROTEIN; HETASTARCH; HUMAN ALBUMIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; RINGER SOLUTION; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; COLLOID; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CRYSTALLOID; DOWN REGULATION; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RANDOMIZED CONTROLLED TRIAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; UPREGULATION; WEIGHT GAIN;

EID: 84861448622     PISSN: 03044920     EISSN: 26660059     Source Type: Journal    
DOI: 10.4077/CJP.2012.BAA028     Document Type: Article

References (30)

1. Aukerman, J., Voepel-Lewis, T., Riegger, L.Q., Siewert, M., Shayevitz, J.R. and Mosca, R. The relationship between extracorporeal circuit prime, albumin, and postoperative weight gain in children. J. Thorac. Cardiovasc. Surg. 12: 408-414, 1998.
2. Barron, M.E., Wilkes, M.M. and Navickis, R.J. A systematic review of the comparative safety of colloids. Arch. Sur. 139: 552-563, 2004.
3. Baumann, H., Richards, C. and Gauldie, J. Interaction among hepatocyte-stimulating factors, interleukin-1, and glucocorticoids for regulation of acute phase plasma proteins in human hepatoma (Hep G2) cells. J. Immunol. 139: 4122-4128, 1987.
4. Biffl, W.L., Moore, E.E., Moore, F.A. and Barnett, C.C. Jr. Interleukin-6 delays neutrophil apoptosis via a mechanism involving platelet-activating factor. J. Trauma 40: 575-578, 1996.
5. Boldt, J., Ducke, M., Kumle, B., Papsdorf, M. and Zurmeye, E.L. Influence of different volume replacement strategies on inflammation and endothelial activation in the elderly undergoing major abdominal surgery. Intensive Care Med. 30: 416-422, 2004.
6. Boldt, J., Suttner, S., Brosch, C., Lehmann, A., Röhm, K. and Mengistu, A. Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy. Anesth. Analg. 109: 1752-1762, 2009.
7. Butler, J., Pathi, V.L., Paton, R.D., Logan, R.W., MacArthur, K., Jamieson, M.P. and Pollock, J.C. Acute-phase responses to cardiopulmonary bypass in children weighing less than 10 kilograms. Ann. Thorac. Surg. 62: 538-542, 1996.
8. Dokka, S., Shi, X., Leonard, S., Wang, L., Castranova, V. and Rojanasakul, Y. Interleukin-10-mediated inhibition of free radical generation in macrophages. Am. J. Physiol. Lung Cell Mol. Physiol. 280: 1196-1202, 2001.
9. Elhabbal, M.H., Smith, L.J., Elliot, M.J. and Strobel, S. Cardiopulmonary bypass tubes and prime solutions stimulate neutrophil adhesion molecules. Cardiovasc. Res. 33: 209-215, 1997.
10. Emmerson, T.E. Unique features of albumin. A brief review. Crit. Care Med. 17: 690-693, 1989.
11. Hall, R., Smith, M. and Rocker, G. The systemic inflammatory response to cardiopulmonary bypass: pathophysiological, therapeutic, and pharmacological considerations. Anesth. Analg. 85: 766-882, 1997.
12. Heeschen, C., Dimmeler, S., Hamm, C.W., Fichtlscherer, S., Boersma, E., Simoons, M.L. and Zeiher, A.M. Serum level of antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 107: 2109-2114, 2003.
13. Kailash, Prasad K. C-reactive protein and cardiovascular diseases. Int. J. Angiol. 12: 1-12, 2003.
14. Liebold, A., Keylb, C. and Birnbauma, D.E. The heart produces but the lungs consume proinflammatory cytokines following cardiopulmonary bypass. Eur. J. Cardiothorac. Surg. 15: 340-345, 1999.
15. Mackiewicz, A., Speroff, T., Ganapathi, M.K. and Kushner, I. Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines. J. Immunol. 146: 3032-3037, 1991.
16. Paparella, D., Yau, T.M. and Young, E. Cardiopulmonary bypass induced inflammation:pathophysiology and treatment. An update. Eur. J. Cardiothorac. Surg. 21: 232-244, 2002.
17. Pepys, M.B., Hirschfield, G.M., Tennent, G.A., Gallimore, J.R., Kahan, M.C., Bellotti, V., Hawkins, P.N., Myers, R.M., Smith, M.D., Polara, A., Cobb, A.J., Ley, S.V., Aquilina, J.A., Robinson, C.V., Sharif, I., Gray, G.A., Sabin, C.A., Jenvey, M.C., Kolstoe, S.E., Thompson, D. and Wood, S.P. Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 440: 1217-1221, 2006.
18. Remick, D.G., Bolgos, G.R., Siddiqui, J., Shin, J. and Nemzek, J.A. Six at six: interleukin-6 measured 6 hours after the initiation of sepsis predicts mortality over 3 days. Shock 17: 463-467, 2002.
19. Russell, J.A., Navickis, R.J. and Wilkes, M.M. Albumin versus crystalloid for pump priming in cardiac surgery: Meta-analysis of controlled trials. J. Thorac. Cardiovasc. Surg. 18: 429-437, 2004,
20. Sade, R.M., Stroud, M.R., Crawford, F.A. Jr, Kratz, J.M., Dearing, J.P. and Bartles, D.M. A prospective randomized study of hydroxyethyl starch, albumin, and lactated Ringer's solution as priming fluid for cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 89: 713-722, 1985.
21. Schneider, S.O., Rensing, H., Gräber, S., Kreuer, S., Kleinschmidt, S., Kreimeier, S., Müller, P., Mathes, A.M. and Biedler, A.E. Impact of platelets and fresh frozen plasma in contrast to red cell concentrate on unstimulated and stimulated cytokine release in an in vitro model of transfusion. Scand. J. Immunol. 70: 101-105, 2009.
22. Singh, U., Devaraj, S., Dasu, M.R., Ciobanu, D., Reusch, J. and Jialal, I. C-Reactive Protein decreases Interleukin-10 secretion in activated human monocyte-derived macrophages via inhibition of cyclic AMP production. Arterioscler. Thromb. Vasc. Biol. 26: 2469-2475, 2006.
23. Singh, U., Devaraj, S. and Jialal, I. CRP decreases tPA activity in HAECs:evidence that CRP is a procoagulant. Arterioscler. Thromb. Vasc. Biol. 25: 2216-2221, 2005.
24. Steinberg, J.B., Kapelanski, D.P., Olson, J.D. and Weiler, J.M. Cytokine and complement levels in patients undergoing cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 106: 1008-1016, 1993.
25. Tamayo, E., 'Alvarez, F.J., Castrodeza, J., Bustamante, R., Gómez-Herreras, J.I., Florez, S. and Rodriguez, R. The inflammatory response to colloids and crystalloids used for pump priming during cardiopulmonary bypass. Acta. Anaesthesiol. Scand. 52: 1204-1212, 2008.
26. Teoh, K.H., Bradley, C.A., Gauldie, J. and Burrows, H. Steroid inhibition of cytokine-mediated vasodilation after warm heart surgery. Circulation 92: 347-353, 1995.
27. Tian, J., Lin, X., Guan, R. and Xu, J.G. The effects of hydroxyethyl starch on lung capillary permeability in endotoxic rats and possible mechanisms. Anesth. Analg. 98: 768-774, 2004.
28. Varga, R., Török, L., Szabó, A., Kovács, F., Keresztes, M., Varga, G., Kaszaki, J. and Boros, M. Effects of colloid solutions on ischemia reperfusion-induced periosteal microcirculatory and inflammatory reactions: comparison of dextran, gelatin, and hydroxyethyl starch. Crit. Care Med. 36: 2828-2837, 2008.
29. Verma, S., Devaraj, S. and Jialal, I. Is CRP an innocent bystander or proatherogenic culprit? CRP promotes atherothrombosis. Circulation 113: 2135-21150, 2006.
30. Wan, S., Izzat, M., Lee, T.W., Wan, I.Y., Tang, N.L. and Yim, A.P. Avoiding cardiopulmonary bypass in multivessel-CABG reduces cytokine response and myocardial injury. Ann. Thorac. Surg. 68: 52-57, 1999.